BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16159812)

  • 1. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.
    Bartunek J; Vanderheyden M; Vandekerckhove B; Mansour S; De Bruyne B; De Bondt P; Van Haute I; Lootens N; Heyndrickx G; Wijns W
    Circulation; 2005 Aug; 112(9 Suppl):I178-83. PubMed ID: 16159812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
    Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
    Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial.
    Colombo A; Castellani M; Piccaluga E; Pusineri E; Palatresi S; Longari V; Canzi C; Sacchi E; Rossi E; Rech R; Gerundini P; Viecca M; Deliliers GL; Rebulla P; Soligo D; Giordano R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):239-48. PubMed ID: 21372740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency.
    Flores-Ramírez R; Uribe-Longoria A; Rangel-Fuentes MM; Gutiérrez-Fajardo P; Salazar-Riojas R; Cervantes-García D; Treviño-Ortiz JH; Benavides-Chereti GJ; Espinosa-Oliveros LP; Limón-Rodríguez RH; Monreal-Puente R; González-Treviño JL; Rojas-Martínez A
    Cardiovasc Revasc Med; 2010; 11(2):72-8. PubMed ID: 20347795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.
    Mansour S; Roy DC; Bouchard V; Nguyen BK; Stevens LM; Gobeil F; Rivard A; Leclerc G; Reeves F; Noiseux N
    J Cardiovasc Transl Res; 2010 Apr; 3(2):153-9. PubMed ID: 20560029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
    Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of intracoronary injection of CD133+ bone marrow stem cells on coronary atherosclerotic progression in patients with STEMI: a COMPARE-AMI IVUS substudy.
    Qiu F; Maehara A; El Khoury R; Généreux P; LaSalle L; Mintz GS; Noiseux N; Roy DC; Gobeil F; Stevens LM; Reeves F; Leclerc G; Rivard A; Mansour S
    Coron Artery Dis; 2016 Jan; 27(1):5-12. PubMed ID: 26340545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial.
    Kang HJ; Kim HS; Zhang SY; Park KW; Cho HJ; Koo BK; Kim YJ; Soo Lee D; Sohn DW; Han KS; Oh BH; Lee MM; Park YB
    Lancet; 2004 Mar; 363(9411):751-6. PubMed ID: 15016484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of autologous bone marrow derived CD34+ stem cells on the left ventricular function following myocardial infarction].
    Balogh L; Czuriga I; Hunyadi J; Galuska L; Kristóf E; Edes I
    Orv Hetil; 2007 Feb; 148(6):243-9. PubMed ID: 17344174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease.
    Caveliers V; De Keulenaer G; Everaert H; Van Riet I; Van Camp G; Verheye S; Roland J; Schoors D; Franken PR; Schots R
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):61-6. PubMed ID: 17372574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT.
    Döbert N; Britten M; Assmus B; Berner U; Menzel C; Lehmann R; Hamscho N; Schächinger V; Dimmeler S; Zeiher AM; Grünwald F
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1146-51. PubMed ID: 15064873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.
    Wollert KC; Meyer GP; Lotz J; Ringes-Lichtenberg S; Lippolt P; Breidenbach C; Fichtner S; Korte T; Hornig B; Messinger D; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Lancet; 2004 Jul 10-16; 364(9429):141-8. PubMed ID: 15246726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging.
    Musialek P; Tekieli L; Kostkiewicz M; Miszalski-Jamka T; Klimeczek P; Mazur W; Szot W; Majka M; Banys RP; Jarocha D; Walter Z; Krupinski M; Pieniazek P; Olszowska M; Zmudka K; Pasowicz M; Kereiakes DJ; Tracz W; Podolec P; Wojakowski W
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):320-8. PubMed ID: 23271789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up.
    Gavira JJ; Herreros J; Perez A; Garcia-Velloso MJ; Barba J; Martin-Herrero F; Cañizo C; Martin-Arnau A; Martí-Climent JM; Hernández M; López-Holgado N; González-Santos JM; Martín-Luengo C; Alegria E; Prósper F
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):799-804. PubMed ID: 16580437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of intracoronary bone marrow cell transplantation: the potential of gated sestamibi SPECT/FDG PET imaging to select patients with maximum benefit from cell therapy.
    Kaminek M; Meluzin J; Panovský R; Metelkova I; Budikova M; Richter M
    Clin Nucl Med; 2010 Oct; 35(10):780-7. PubMed ID: 20838286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
    Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
    Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
    Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
    Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary administration of stem cells in patients with acute myocardial infarction - angiographic follow-up.
    Peruga J; Plewka M; Kasprzak J; Jezewski T; Wierzbicka A; Robak T; Krzemińska-Pakuła M
    Kardiol Pol; 2009 May; 67(5):477-84. PubMed ID: 19521932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell therapy for the broken heart: mini-organ transplantation.
    Mansour S; Roy DC; Lemieux B; Ouellet C; Stevens LM; Noiseux N
    Transplant Proc; 2009 Oct; 41(8):3353-7. PubMed ID: 19857748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.